| Literature DB >> 27383820 |
Cristina M Villanueva1, Esther Gracia-Lavedan, Cristina Bosetti, Elena Righi, Antonio José Molina, Vicente Martín, Elena Boldo, Nuria Aragonés, Beatriz Perez-Gomez, Marina Pollan, Ines Gomez Acebo, Jone M Altzibar, Ana Jiménez Zabala, Eva Ardanaz, Rosana Peiró, Adonina Tardón, Maria Dolores Chirlaque, Alessandra Tavani, Jerry Polesel, Diego Serraino, Federica Pisa, Gemma Castaño-Vinyals, Ana Espinosa, Nadia Espejo-Herrera, Margarita Palau, Victor Moreno, Carlo La Vecchia, Gabriella Aggazzotti, Mark J Nieuwenhuijsen, Manolis Kogevinas.
Abstract
BACKGROUND: Evidence on the association between colorectal cancer and exposure to disinfection by-products in drinking water is inconsistent.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27383820 PMCID: PMC5226692 DOI: 10.1289/EHP155
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Characteristics of the study population: 2,047 cases of colorectal cancer and 3,718 controls.
| Variable | Cases | Controls |
|---|---|---|
| Age (years), mean (SD) | 67 ± 10 | 64 ± 11 |
| Sex | ||
| Men | 1,317 (64.3) | 1,943 (52.3) |
| Women | 730 (35.7) | 1,775 (47.7) |
| Area | ||
| Asturias (Spain) | 70 (3.4) | 211 (5.7) |
| Barcelona (Spain) | 635 (31.0) | 957 (25.7) |
| Cantabria (Spain) | 125 (6.1) | 282 (7.6) |
| Guipuzcoa (Spain) | 113 (5.5) | 329 (8.9) |
| León (Spain) | 294 (14.4) | 360 (9.7) |
| Madrid (Spain) | 204 (10.0) | 670 (18.0) |
| Murcia (Spain) | 28 (1.4) | 39 (1.1) |
| Navarra (Spain) | 102 (5.0) | 234 (6.3) |
| Valencia (Spain) | 76 (3.7) | 133 (3.6) |
| Milano (Italy) | 215 (10.5) | 301 (8.1) |
| Pordenone/Udine (Italy) | 185 (9.0) | 202 (5.4) |
| Education | ||
| < Primary school | 519 (25.4) | 592 (15.9) |
| Primary school | 766 (37.5) | 1,234 (33.2) |
| Secondary school | 566 (27.7) | 1,182 (31.8) |
| University | 190 (9.3) | 707 (19.0) |
| Missing | 6 | 3 |
| Smoking status | ||
| Never | 841 (41.4) | 1,629 (43.9) |
| Former | 821 (40.4) | 1,290 (34.8) |
| Current | 371 (18.2) | 789 (21.3) |
| Missing | 14 | 10 |
| Nonsteroidal antiinflammatory drug consumption | ||
| No | 1,382 (69.7) | 2,237 (62.3) |
| Yes | 600 (30.3) | 1,352 (37.7) |
| Missing | 65 | 129 |
| Body mass index (kg/m2) | ||
| < 25 | 676 (33.0) | 1,391 (37.8) |
| 25–29.9 | 909 (44.4) | 1,555 (42.3) |
| ≥ 30 | 461 (22.5) | 734 (20.0) |
| Missing | 1 | 38 |
| Leisure physical activity (adult life average) | ||
| 0 METs | 627 (30.6) | 1,011 (27.4) |
| 0–8 (8.5) METs | 698 (34.1) | 1,324 (35.9) |
| 8–16 (34.4) METs | 294 (14.4) | 582 (15.8) |
| > 16 (34.4) METs | 428 (20.9) | 767 (20.8) |
| Missing | 0 | 34 |
| Family history of colorectal cancer (first degree) | ||
| No | 1,648 (85.4) | 3,246 (92.0) |
| Yes | 281 (15.6) | 284 (8.0) |
| Missing | 118 | 188 |
| Drinking-water type at the place of longest residence | ||
| Tap (municipal) | 1,185 (58%) | 2,474 (67%) |
| Bottled | 655 (32%) | 1,014 (27%) |
| Private well | 198 (10%) | 227 (6%) |
| Missing | 9 | 3 |
| Number of residences | 3.2 ± 1.5 | 3.3 ± 1.6 |
| Years at the place of longest residence | 35.6 ± 12.0 | 31.8 ± 12.1 |
| Average THM concentration in residential tap water (μg/L) | 44.8 ± 43.9 | 40.3 ± 34.2 |
| Average THM ingestion from residential tap water (μg/day) | 28.1 ± 48.8 | 25.9 ± 36.4 |
| Average showering/bathing THM concentrations (min/day × μg/L) | 284.7 ± 406.4 | 266.6 ± 311.5 |
| Notes: MET, metabolic equivalent; THM, trihalomethane. The table excludes subjects with inadequate THM exposure data and 16 observations with low-quality interviews. | ||
Figure 1Distribution of average residential trihalomethane (THM) exposure among subjects with THM estimates for ≥ 70% of the exposure window (age 18 to 2 years before the interview) from reliable interviews. (A) Average concentrations at the tap (micrograms/liter), n = 5,291. (B) Average ingested levels (micrograms/day), n = 5,731. All areas correspond to Spain except Milano and Pordenone/Udine (Italy). Boxes are delimited by the 25th (left hinge) and 75th (right hinge) percentiles, the central vertical line represents the median value, the whiskers represent ± 1.5 times the interquartile range, and the points outside the whiskers represent outliers.
Association between average trihalomethane (THM) concentrations in residential tap water and colorectal cancer. Odds ratios (ORs) and 95% confidence intervals (CIs) among 1,837 cases and 3,454 controls.
| Exposure | All ( | Men ( | Women ( | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Cases | Controls | OR | Cases | Controls | OR | Cases | Controls | OR | |
| Total THMs (μg/L) | |||||||||
| < 16.2 | 591 | 741 | 1 | 393 | 447 | 1 | 196 | 294 | 1 |
| 16.2–29.5 | 378 | 954 | 0.57 (0.45, 0.72) | 241 | 407 | 0.56 (0.41, 0.77) | 137 | 547 | 0.62 (0.41, 0.93) |
| 29.5–62 | 323 | 1,007 | 0.44 (0.33, 0.58) | 193 | 530 | 0.38 (0.27, 0.55) | 130 | 477 | 0.60 (0.38, 0.93) |
| > 62 | 545 | 752 | 0.92 (0.66, 1.28) | 349 | 417 | 1.04 (0.68, 1.60) | 196 | 335 | 0.68 (0.39, 1.20) |
| Chloroform (μg/L) | |||||||||
| < 6 | 589 | 744 | 1 | 387 | 446 | 1 | 200 | 298 | 1 |
| 6–17.4 | 435 | 895 | 0.69 (0.55, 0.87) | 268 | 404 | 0.69 (0.51, 0.93) | 167 | 491 | 0.71 (0.49, 1.03) |
| 17.4–23.4 | 515 | 798 | 0.68 (0.53, 0.87) | 335 | 384 | 0.73 (0.53, 1.01) | 180 | 414 | 0.65 (0.43, 0.97) |
| > 23.4 | 298 | 1,017 | 0.31 (0.24, 0.41) | 186 | 567 | 0.26 (0.18, 0.37) | 112 | 450 | 0.46 (0.29, 0.72) |
| Brominated THMs (μg/L) | |||||||||
| < 3.7 | 541 | 792 | 1 | 348 | 483 | 1 | 191 | 309 | 1 |
| 3.7–9.0 | 387 | 943 | 0.77 (0.60, 0.98) | 238 | 419 | 0.73 (0.53, 1.01) | 149 | 524 | 0.78 (0.52, 1.17) |
| 9.0–41.8 | 368 | 963 | 0.55 (0.38, 0.79) | 241 | 479 | 0.57 (0.36, 0.90) | 127 | 484 | 0.49 (0.26, 0.91) |
| > 41.8 | 541 | 756 | 1.00 (0.65, 1.53) | 349 | 420 | 1.43 (0.83, 2.46) | 192 | 336 | 0.44 (0.21, 0.92) |
Figure 2Exposure–response relationship between residential trihalomethane (THM) concentrations (x-axis, in micrograms/liter) and colorectal cancer (y-axis, expressed as odds ratios, ORs) among 1,837 cases and 3,454 controls. (A) Men. (B) Women. Smoothed spline with 3 degrees of freedom from general additive models adjusted for sex, age, area, education, smoking, physical activity, nonsteroidal antiinflammatory drug use, and family history of cancer. Subjects with unsatisfactory questionnaires and subjects with THMs estimated for < 70% of the exposure window were excluded. p-Value gain compared with linearity is < 0.001 for all models, except for chloroform in women (p-value = 0.38). Tick marks above the x-axes represent observations, and the dashed lines represent the 95% confidence intervals (CIs).
Interaction between polymorphisms in CYP2E1 and trihalomethane (THM) exposure, dichotomized at the 75th percentile. Odds ratios (ORs) and 95% confidence intervals (CIs) among 981 cases and 2,204 controls.
| Gene, SNP | Genotype | Cases | Controls | Total THMs (> vs. ≤ 60 μg/L) | Brominated THMs (> vs. ≤ 40 μg/L) | Chloroform (> vs. ≤ 20 μg/L) | |||
|---|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | Nominal | OR (95% CI) | Nominal | OR (95% CI) | Nominal | ||||
| rs2070675 | CC | 682 | 1,496 | 3.5 (2.4, 5.1) | 0.029 | 4.1 (2.7, 6.0) | 0.009 | 0.4 (0.3, 0.6) | 0.646 |
| CT/TT | 298 | 707 | 2.3 (1.3, 4.0) | 2.1 (1.2, 3.7) | 0.6 (0.4, 0.9) | ||||
| rs915907 | CC | 710 | 1,566 | 3.3 (2.2, 4.7) | 0.031 | 3.9 (2.7, 5.8) | 0.009 | 0.4 (0.3, 0.5) | 0.392 |
| AC/AA | 252 | 618 | 2.6 (1.4, 5.0) | 2.3 (1.2, 4.3) | 0.8 (0.5, 1.2) | ||||
| rs8192775 | GG | 850 | 1,884 | 3.1 (2.2, 4.4) | 0.103 | 3.7 (2.6, 5.3) | 0.021 | 0.5 (0.4, 0.6) | 0.383 |
| AG/AA | 131 | 320 | 2.7 (1.1, 6.5) | 1.7 (0.8, 3.9) | 0.5 (0.2, 1.0) | ||||
| rs743535 | GG | 838 | 1,823 | 3.0 (2.1, 4.3) | 0.056 | 3.7 (2.6, 5.3) | 0.019 | 0.5 (0.3, 0.6) | 0.066 |
| AG/AA | 142 | 381 | 3.4 (1.5, 7.8) | 2.0 (0.9, 4.3) | 0.5 (0.3, 0.9) | ||||
| Notes: SNP, single nucleotide polymorphism. | |||||||||
Association between average trihalomethane (THM) ingestion in the residence and colorectal cancer. Odds ratio (ORs) and 95% confidence intervals (CIs) among 2,047 cases and 3,684 controls.
| Exposure | All ( | Men ( | Women ( | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Cases | Controls | OR | Cases | Controls | OR | Cases | Controls | OR | |
| Total THMs (μg/day) | |||||||||
| < 1.3 | 601 | 836 | 1 | 390 | 491 | 1 | 209 | 345 | 1 |
| 1.3–12.2 | 555 | 882 | 0.98 (0.83, 1.17) | 372 | 448 | 0.99 (0.79, 1.25) | 183 | 434 | 1.04 (0.78, 1.39) |
| 12.2–32.3 | 395 | 1,039 | 0.74 (0.61, 0.91) | 245 | 474 | 0.74 (0.58, 0.96) | 150 | 565 | 0.83 (0.60, 1.14) |
| > 32.3 | 496 | 927 | 0.83 (0.68, 1.00) | 310 | 509 | 0.82 (0.64, 1.05) | 186 | 418 | 0.86 (0.63, 1.17) |
| Chloroform (μg/day) | |||||||||
| < 0.2 | 621 | 816 | 1 | 403 | 471 | 1 | 216 | 345 | 1 |
| 0.2–5.3 | 537 | 897 | 0.87 (0.74, 1.03) | 356 | 489 | 0.86 (0.70, 1.05) | 181 | 408 | 0.98 (0.75, 1.29) |
| 5.3–16.6 | 477 | 955 | 0.82 (0.69, 0.98) | 310 | 435 | 0.89 (0.71, 1.12) | 167 | 520 | 0.78 (0.58, 1.04) |
| > 16.6 | 412 | 1,016 | 0.67 (0.56, 0.82) | 248 | 527 | 0.63 (0.49, 0.81) | 164 | 489 | 0.74 (0.54, 1.01) |
| Brominated THMs (μg/day) | |||||||||
| < 0.7 | 590 | 847 | 1 | 384 | 496 | 1 | 204 | 351 | 1 |
| 0.7–3.7 | 521 | 918 | 1.04 (0.86, 1.26) | 332 | 467 | 0.99 (0.78, 1.26) | 189 | 451 | 1.26 (0.91, 1.74) |
| 3.7–11.9 | 412 | 1,024 | 0.79 (0.65, 0.96) | 262 | 460 | 0.76 (0.59, 0.98) | 150 | 564 | 0.85 (0.61, 1.19) |
| > 11.9 | 524 | 895 | 0.83 (0.68, 1.02) | 339 | 499 | 0.88 (0.68, 1.14) | 185 | 396 | 0.83 (0.60, 1.15) |
Association between colorectal cancer and shower/bath trihalomethane (THM) levels. Odds ratios (ORs) and 95% confidence intervals (CIs) among 1,702 cases and 3,269 controls.
| Exposure | All ( | Men ( | Women ( | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Cases | Controls | OR | Cases | Controls | OR | Cases | Controls | OR | |
| Total THMs (μg/L × min/day) | |||||||||
| < 60.7 | 550 | 701 | 1 | 363 | 444 | 1 | 185 | 257 | 1 |
| 60.7–158.7 | 382 | 867 | 0.72 (0.58, 0.89) | 244 | 420 | 0.76 (0.58, 0.99) | 138 | 447 | 0.67 (0.47, 0.97) |
| 158.7–336.7 | 329 | 920 | 0.60 (0.48, 0.76) | 203 | 416 | 0.68 (0.50, 0.92) | 126 | 504 | 0.54 (0.37, 0.80) |
| > 336.7 | 441 | 781 | 0.81 (0.63, 1.06) | 279 | 424 | 0.92 (0.65, 1.29) | 162 | 357 | 0.71 (0.46, 1.09) |
| Chloroform (μg/L × min/day) | |||||||||
| < 26.1 | 550 | 701 | 1 | 361 | 435 | 1 | 188 | 266 | 1 |
| 26.7–72.5 | 444 | 804 | 0.85 (0.70, 1.03) | 284 | 405 | 0.90 (0.70, 1.16) | 159 | 399 | 0.82 (0.59, 1.13) |
| 72.5–143.5 | 373 | 861 | 0.65 (0.53, 0.81) | 237 | 445 | 0.68 (0.51, 0.89) | 136 | 416 | 0.68 (0.48, 0.97) |
| > 143.5 | 335 | 903 | 0.66 (0.52, 0.83) | 207 | 419 | 0.73 (0.54, 0.99) | 128 | 484 | 0.60 (0.41, 0.88) |
| Brominated THMs (μg/L × min/day) | |||||||||
| < 16.5 | 539 | 712 | 1 | 345 | 455 | 1 | 192 | 257 | 1 |
| 16.5–51.0 | 339 | 911 | 0.66 (0.53, 0.83) | 217 | 431 | 0.76 (0.57, 1.01) | 122 | 480 | 0.52 (0.36, 0.74) |
| 51.0–178.0 | 345 | 904 | 0.61 (0.47, 0.80) | 220 | 401 | 0.78 (0.56, 1.09) | 125 | 503 | 0.43 (0.28, 0.65) |
| > 178 | 479 | 742 | 0.90 (0.65, 1.25) | 307 | 417 | 1.25 (0.83, 1.89) | 172 | 325 | 0.55 (0.32, 0.95) |